I think the question is 100% can they execute in the u.s.
Australia and NZ look great and seem to show that it can work, but the price reduction in u.s. and the offering off free trials and we're still yet to see a meaningful uptick in take up raises my only concern really. I'll probably re enter the moment that concern is removed
